SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-013837
Filing Date
2023-04-21
Accepted
2023-04-21 16:06:57
Documents
21

Document Format Files

Seq Description Document Type Size
1 DEF 14A beam-20230421.htm   iXBRL DEF 14A 1653822
2 GRAPHIC img43031840_0.jpg GRAPHIC 5356
3 GRAPHIC img43031840_1.jpg GRAPHIC 3067
4 GRAPHIC img43031840_2.jpg GRAPHIC 5356
5 GRAPHIC img43031840_3.jpg GRAPHIC 167930
6 GRAPHIC img43031840_4.jpg GRAPHIC 162438
7 GRAPHIC img43031840_5.jpg GRAPHIC 454776
8 GRAPHIC img43031840_6.jpg GRAPHIC 245233
  Complete submission text file 0000950170-23-013837.txt   4787592

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20230421_pre.xml EX-101.PRE 8361
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20230421.xsd EX-101.SCH 5735
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT beam-20230421_def.xml EX-101.DEF 6658
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20230421_lab.xml EX-101.LAB 15629
15 EXTRACTED XBRL INSTANCE DOCUMENT beam-20230421_htm.xml XML 246807
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39208 | Film No.: 23836394
SIC: 2836 Biological Products, (No Diagnostic Substances)